InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by FRIEDMAN CATHY, Director. Officer active across 3 companies, notably Lyell Immunopharma, Inc.. Cumulatively, 7 disclosures have been recorded. The latest transaction was disclosed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations7 total
09,945 shares0
Class A Common Stock
SEC:0001209191-22-038080:0·
05,500 shares0
Common Stock
SEC:0001209191-22-004785·
05,500 shares0
Common Stock
SEC:0001209191-22-004785:0·
03,765,842 shares0
Common Stock
SEC:0001209191-21-069485·
03,765,842 shares0
Common Stock
SEC:0001209191-21-069485:0·
3,765,842 shares
Common Stock
SEC:0001209191-21-042795·
3,765,842 shares
Common Stock
SEC:0001209191-21-042795:0·
7 of 7 declarations
About FRIEDMAN CATHY
Cathy Friedman is a Board Member at Lyell Immunopharma, Inc., Radius Health, Inc., and Seer, Inc. She plays a key role in the governance of these companies, participating in strategic decision-making and guiding operations. Her experience in the biopharmaceutical sector is an asset to the boards, allowing these companies to focus on innovation and growth.
